- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06804629
The Resistance Exercise Training for Worry Trial: Replication and Expansion (RETRAIN REP-EX)
January 27, 2025 updated by: University of Limerick
Acute and Chronic Effects of Guidelines-Based Resistance Exercise Training Compared to a Low Intensity SHAM Attention Control Among Young Adult Women with Analogue Generalized Anxiety Disorder: a Protocol for a Randomized Controlled Trial.
This protocol details the full methods of a ten-week moderate-to-high intensity, guidelines-based resistance exercise training intervention compared to a low intensity sham attention control among young adult women with analogue Generalized Anxiety Disorder.
Study Overview
Status
Completed
Conditions
Detailed Description
A recent clinical trial supported the anxiolytic effects of regularly-performed resistance exercise training compared to a waitlist control among young adults with and without at least subclinical, or analogue, Generalized Anxiety Disorder.
Although the evidence to date is promising, waitlist control conditions cannot control for potential social and psychological benefits of engaging with most interventions, including social contact, expectations for improvement, and mastery experiences, which could potentially be achieved from easier activities.
Therefore, this trial aims to replicate the previously investigated World Health Organization and American College of Sports Medicine guidelines-based resistance exercise training program, and expand on this research by more rigorously examining the effects on anxiety and worry symptoms, independent of potential social and psychological benefits of engagement with the intervention.
Consequently, this trial quantifies the acute and chronic effects of moderate-to-high intensity, guidelines-based resistance exercise training compared to a low intensity SHAM attention control on signs and symptoms of Generalized Anxiety Disorder among at-risk young adult women with Analogue Generalized Anxiety Disorder.
This trial consists of a two-week familiarization protocol, eight weeks of formal resistance exercise training, and a one-month post-intervention follow-up.
Study Type
Interventional
Enrollment (Actual)
68
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Munster
-
Limerick, Munster, Ireland, V94 T9PX
- University of Limerick
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Female
- Aged 18-40y
- Met criteria for analogue Generalized Anxiety Disorder
Exclusion Criteria:
- Medical contraindications to doing resistance exercise training
- Currently involved in formal resistance exercise training
- Currently pregnant or post-partum
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Moderate-to-High Intensity Resistance Exercise Training
Moderate-to-high intensity, guidelines-based resistance exercise training completed at 70-80% of the estimated one-repetition maximum
|
Resistance exercise training was designed in accordance with World Health Organization and American College of Sports Medicine guidelines.
The eight-week, twice-weekly intervention was designed such that moderate-to-high intensity participants could achieve two sets of 8-12 repetitions of the eight exercises before volitional fatigue, a deterioration in lifting form, or failure to complete a repetition, using loads of approximately 70-80% of their estimated one-repetition maximum.
Completed in the following order, the exercises were: barbell back squat, barbell bench press, hexagon bar deadlift, barbell bent over row, dumbbell lunges, seated dumbbell lateral raises, weighted or unweighted abdominal crunches, and seated dumbbell bicep curls.
There was one minute of rest between each set, and two minutes of rest between each exercise.
If participants could complete two sets of 12 repetitions, load was increased gradually by approximately 5% in the following session.
Other Names:
|
|
Sham Comparator: Low Intensity SHAM Resistance Exercise Training Attention Control
Low intensity SHAM Resistance Exercise Training completed at 20% of the estimated one-repetition maximum
|
The low intensity SHAM condition was matched all features of engagement with the moderate-to-high intensity intervention apart from load, and load progression.
Low intensity SHAM participants completed the same program with loads of approximately 20% of their estimated one-repetition maximum.
To maintain low intensity, repetitions completed on the main, heavier lifts (i.e., back squat, bench press, deadlift, bent over row) were increased from 10 in one session to 12 in the next; load was then increased by approximately 10% in the following session, and 10 reps were performed again.
On the remaining lighter, assistance lifts, eight repetitions were performed per set, then one repetition was added to both sets in each session, and load was increased by the smallest increment possible when two sets of 12 repetitions were performed.
Borg's 6-20 rating of perceived exertion scores were used to monitor intensity, such that if scores exceeded 11, load and reps were not progressed.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Analogue Generalized Anxiety Disorder Status
Time Frame: Baseline
|
Psychiatric Diagnostic Screening Questionnaire Generalized Anxiety Disorder subscale score of 6 or greater (Zimmerman & Mattia, 2001)
|
Baseline
|
|
Analogue Generalized Anxiety Disorder Status
Time Frame: Week 1
|
Psychiatric Diagnostic Screening Questionnaire Generalized Anxiety Disorder subscale score of 6 or greater (Zimmerman & Mattia, 2001)
|
Week 1
|
|
Analogue Generalized Anxiety Disorder Status
Time Frame: Week 4
|
Psychiatric Diagnostic Screening Questionnaire Generalized Anxiety Disorder subscale score of 6 or greater (Zimmerman & Mattia, 2001)
|
Week 4
|
|
Analogue Generalized Anxiety Disorder Status
Time Frame: Week 8
|
Psychiatric Diagnostic Screening Questionnaire Generalized Anxiety Disorder subscale score of 6 or greater (Zimmerman & Mattia, 2001)
|
Week 8
|
|
Analogue Generalized Anxiety Disorder Status
Time Frame: Week 12
|
Psychiatric Diagnostic Screening Questionnaire Generalized Anxiety Disorder subscale score of 6 or greater (Zimmerman & Mattia, 2001)
|
Week 12
|
|
Analogue Generalized Anxiety Disorder Status
Time Frame: Baseline
|
Penn State Worry Questionnaire of 45 or greater (Meyer et al., 1990)
|
Baseline
|
|
Analogue Generalized Anxiety Disorder Status
Time Frame: Week 1
|
Penn State Worry Questionnaire of 45 or greater (Meyer et al., 1990)
|
Week 1
|
|
Analogue Generalized Anxiety Disorder Status
Time Frame: Week 4
|
Penn State Worry Questionnaire of 45 or greater (Meyer et al., 1990)
|
Week 4
|
|
Analogue Generalized Anxiety Disorder Status
Time Frame: Week 8
|
Penn State Worry Questionnaire of 45 or greater (Meyer et al., 1990)
|
Week 8
|
|
Analogue Generalized Anxiety Disorder Status
Time Frame: Week 12
|
Penn State Worry Questionnaire of 45 or greater (Meyer et al., 1990)
|
Week 12
|
|
Worry Symptoms
Time Frame: Baseline
|
16-item Penn State Worry Questionnaire (Meyer et al., 1990)
|
Baseline
|
|
Worry Symptoms
Time Frame: Pre-week 1
|
16-item Penn State Worry Questionnaire (Meyer et al., 1990)
|
Pre-week 1
|
|
Worry Symptoms
Time Frame: Week 1
|
16-item Penn State Worry Questionnaire (Meyer et al., 1990)
|
Week 1
|
|
Worry Symptoms
Time Frame: Week 2
|
16-item Penn State Worry Questionnaire (Meyer et al., 1990)
|
Week 2
|
|
Worry Symptoms
Time Frame: Week 3
|
16-item Penn State Worry Questionnaire (Meyer et al., 1990)
|
Week 3
|
|
Worry Symptoms
Time Frame: Week 4
|
16-item Penn State Worry Questionnaire (Meyer et al., 1990)
|
Week 4
|
|
Worry Symptoms
Time Frame: Week 5
|
16-item Penn State Worry Questionnaire (Meyer et al., 1990)
|
Week 5
|
|
Worry Symptoms
Time Frame: Week 6
|
16-item Penn State Worry Questionnaire (Meyer et al., 1990)
|
Week 6
|
|
Worry Symptoms
Time Frame: Week 7
|
16-item Penn State Worry Questionnaire (Meyer et al., 1990)
|
Week 7
|
|
Worry Symptoms
Time Frame: Week 8
|
16-item Penn State Worry Questionnaire (Meyer et al., 1990)
|
Week 8
|
|
Worry Symptoms
Time Frame: Week 12
|
16-item Penn State Worry Questionnaire (Meyer et al., 1990)
|
Week 12
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mood
Time Frame: Baseline
|
Subscales of the Profile of Mood States - Brief Form (McNair et al., 1992)
|
Baseline
|
|
Mood
Time Frame: Week 1
|
Subscales of the Profile of Mood States - Brief Form (McNair et al., 1992)
|
Week 1
|
|
Mood
Time Frame: Week 2
|
Subscales of the Profile of Mood States - Brief Form (McNair et al., 1992)
|
Week 2
|
|
Mood
Time Frame: Week 3
|
Subscales of the Profile of Mood States - Brief Form (McNair et al., 1992)
|
Week 3
|
|
Mood
Time Frame: Week 4
|
Subscales of the Profile of Mood States - Brief Form (McNair et al., 1992)
|
Week 4
|
|
Mood
Time Frame: Week 5
|
Subscales of the Profile of Mood States - Brief Form (McNair et al., 1992)
|
Week 5
|
|
Mood
Time Frame: Week 6
|
Subscales of the Profile of Mood States - Brief Form (McNair et al., 1992)
|
Week 6
|
|
Mood
Time Frame: Week 7
|
Subscales of the Profile of Mood States - Brief Form (McNair et al., 1992)
|
Week 7
|
|
Mood
Time Frame: Week 8
|
Subscales of the Profile of Mood States - Brief Form (McNair et al., 1992)
|
Week 8
|
|
Anxiety Symptoms
Time Frame: Baseline
|
Trait anxiety was measured using the Trait (STAI-Y2) subscale of the State-Trait Anxiety Inventory (Spielberger, 2010)
|
Baseline
|
|
Anxiety Symptoms
Time Frame: Pre-week 1
|
Trait anxiety was measured using the Trait (STAI-Y2) subscale of the State-Trait Anxiety Inventory (Spielberger, 2010)
|
Pre-week 1
|
|
Anxiety Symptoms
Time Frame: Week 1
|
Trait anxiety was measured using the Trait (STAI-Y2) subscale of the State-Trait Anxiety Inventory (Spielberger, 2010)
|
Week 1
|
|
Anxiety Symptoms
Time Frame: Week 2
|
Trait anxiety was measured using the Trait (STAI-Y2) subscale of the State-Trait Anxiety Inventory (Spielberger, 2010)
|
Week 2
|
|
Anxiety Symptoms
Time Frame: Week 3
|
Trait anxiety was measured using the Trait (STAI-Y2) subscale of the State-Trait Anxiety Inventory (Spielberger, 2010)
|
Week 3
|
|
Anxiety Symptoms
Time Frame: Week 4
|
Trait anxiety was measured using the Trait (STAI-Y2) subscale of the State-Trait Anxiety Inventory (Spielberger, 2010)
|
Week 4
|
|
Anxiety Symptoms
Time Frame: Week 5
|
Trait anxiety was measured using the Trait (STAI-Y2) subscale of the State-Trait Anxiety Inventory (Spielberger, 2010)
|
Week 5
|
|
Anxiety Symptoms
Time Frame: Week 6
|
Trait anxiety was measured using the Trait (STAI-Y2) subscale of the State-Trait Anxiety Inventory (Spielberger, 2010)
|
Week 6
|
|
Anxiety Symptoms
Time Frame: Week 7
|
Trait anxiety was measured using the Trait (STAI-Y2) subscale of the State-Trait Anxiety Inventory (Spielberger, 2010)
|
Week 7
|
|
Anxiety Symptoms
Time Frame: Week 8
|
Trait anxiety was measured using the Trait (STAI-Y2) subscale of the State-Trait Anxiety Inventory (Spielberger, 2010)
|
Week 8
|
|
Anxiety Symptoms
Time Frame: Week 12
|
Trait anxiety was measured using the Trait (STAI-Y2) subscale of the State-Trait Anxiety Inventory (Spielberger, 2010)
|
Week 12
|
|
Anxiety Symptoms
Time Frame: Baseline
|
State anxiety was measured using the State (STAI-Y1) subscale of the State-Trait Anxiety Inventory (Spielberger, 2010)
|
Baseline
|
|
Anxiety Symptoms
Time Frame: Pre-acute resistance exercise bout week 1
|
State anxiety was measured using the State (STAI-Y1) subscale of the State-Trait Anxiety Inventory (Spielberger, 2010)
|
Pre-acute resistance exercise bout week 1
|
|
Anxiety Symptoms
Time Frame: Post-acute resistance exercise bout week 1
|
State anxiety was measured using the State (STAI-Y1) subscale of the State-Trait Anxiety Inventory (Spielberger, 2010)
|
Post-acute resistance exercise bout week 1
|
|
Anxiety Symptoms
Time Frame: Pre-acute resistance exercise bout week 8
|
State anxiety was measured using the State (STAI-Y1) subscale of the State-Trait Anxiety Inventory (Spielberger, 2010)
|
Pre-acute resistance exercise bout week 8
|
|
Anxiety Symptoms
Time Frame: Post-acute resistance exercise bout week 8
|
State anxiety was measured using the State (STAI-Y1) subscale of the State-Trait Anxiety Inventory (Spielberger, 2010)
|
Post-acute resistance exercise bout week 8
|
|
Depressive Symptoms
Time Frame: Baseline
|
16-item Quick Inventory of Depressive Symptomatology (Rush et al., 2003)
|
Baseline
|
|
Depressive Symptoms
Time Frame: Pre-week 1
|
16-item Quick Inventory of Depressive Symptomatology (Rush et al., 2003)
|
Pre-week 1
|
|
Depressive Symptoms
Time Frame: Week 1
|
16-item Quick Inventory of Depressive Symptomatology (Rush et al., 2003)
|
Week 1
|
|
Depressive Symptoms
Time Frame: Week 2
|
16-item Quick Inventory of Depressive Symptomatology (Rush et al., 2003)
|
Week 2
|
|
Depressive Symptoms
Time Frame: Week 3
|
16-item Quick Inventory of Depressive Symptomatology (Rush et al., 2003)
|
Week 3
|
|
Depressive Symptoms
Time Frame: Week 4
|
16-item Quick Inventory of Depressive Symptomatology (Rush et al., 2003)
|
Week 4
|
|
Depressive Symptoms
Time Frame: Week 5
|
16-item Quick Inventory of Depressive Symptomatology (Rush et al., 2003)
|
Week 5
|
|
Depressive Symptoms
Time Frame: Week 6
|
16-item Quick Inventory of Depressive Symptomatology (Rush et al., 2003)
|
Week 6
|
|
Depressive Symptoms
Time Frame: Week 7
|
16-item Quick Inventory of Depressive Symptomatology (Rush et al., 2003)
|
Week 7
|
|
Depressive Symptoms
Time Frame: Week 8
|
16-item Quick Inventory of Depressive Symptomatology (Rush et al., 2003)
|
Week 8
|
|
Depressive Symptoms
Time Frame: Week 12
|
16-item Quick Inventory of Depressive Symptomatology (Rush et al., 2003)
|
Week 12
|
|
Mood
Time Frame: Pre-week 1
|
Subscales of the Profile of Mood States - Brief Form (McNair et al., 1992)
|
Pre-week 1
|
|
Mood
Time Frame: Week 12
|
Subscales of the Profile of Mood States - Brief Form (McNair et al., 1992)
|
Week 12
|
|
Mood
Time Frame: Pre-acute resistance exercise bout week 1
|
Subscales of the Profile of Mood States - Brief Form (McNair et al., 1992)
|
Pre-acute resistance exercise bout week 1
|
|
Mood
Time Frame: Post-acute resistance exercise bout week 1
|
Subscales of the Profile of Mood States - Brief Form (McNair et al., 1992)
|
Post-acute resistance exercise bout week 1
|
|
Mood
Time Frame: Pre-acute resistance exercise bout week 8
|
Subscales of the Profile of Mood States - Brief Form (McNair et al., 1992)
|
Pre-acute resistance exercise bout week 8
|
|
Mood
Time Frame: Post-acute resistance exercise bout week 8
|
Subscales of the Profile of Mood States - Brief Form (McNair et al., 1992)
|
Post-acute resistance exercise bout week 8
|
|
Analogue Major Depressive Disorder Status
Time Frame: Baseline
|
Psychiatric Diagnostic Screening Questionnaire Major Depressive Disorder subscale score of 9 or greater (Zimmerman & Mattia, 2001)
|
Baseline
|
|
Analogue Major Depressive Disorder Status
Time Frame: Week 1
|
Psychiatric Diagnostic Screening Questionnaire Major Depressive Disorder subscale score of 9 or greater (Zimmerman & Mattia, 2001)
|
Week 1
|
|
Analogue Major Depressive Disorder Status
Time Frame: Week 4
|
Psychiatric Diagnostic Screening Questionnaire Major Depressive Disorder subscale score of 9 or greater (Zimmerman & Mattia, 2001)
|
Week 4
|
|
Analogue Major Depressive Disorder Status
Time Frame: Week 8
|
Psychiatric Diagnostic Screening Questionnaire Major Depressive Disorder subscale score of 9 or greater (Zimmerman & Mattia, 2001)
|
Week 8
|
|
Analogue Major Depressive Disorder Status
Time Frame: Week 12
|
Psychiatric Diagnostic Screening Questionnaire Major Depressive Disorder subscale score of 9 or greater (Zimmerman & Mattia, 2001)
|
Week 12
|
|
Analogue Panic Disorder Status
Time Frame: Baseline
|
Psychiatric Diagnostic Screening Questionnaire Panic Disorder subscale score of 4 or greater (Zimmerman & Mattia, 2001)
|
Baseline
|
|
Analogue Panic Disorder Status
Time Frame: Week 1
|
Psychiatric Diagnostic Screening Questionnaire Panic Disorder subscale score of 4 or greater (Zimmerman & Mattia, 2001)
|
Week 1
|
|
Analogue Panic Disorder Status
Time Frame: Week 4
|
Psychiatric Diagnostic Screening Questionnaire Panic Disorder subscale score of 4 or greater (Zimmerman & Mattia, 2001)
|
Week 4
|
|
Analogue Panic Disorder Status
Time Frame: Week 8
|
Psychiatric Diagnostic Screening Questionnaire Panic Disorder subscale score of 4 or greater (Zimmerman & Mattia, 2001)
|
Week 8
|
|
Analogue Panic Disorder Status
Time Frame: Week 12
|
Psychiatric Diagnostic Screening Questionnaire Panic Disorder subscale score of 4 or greater (Zimmerman & Mattia, 2001)
|
Week 12
|
|
Analogue Social Anxiety Disorder Status
Time Frame: Baseline
|
Psychiatric Diagnostic Screening Questionnaire Social Anxiety Disorder subscale score of 4 or greater (Zimmerman & Mattia, 2001)
|
Baseline
|
|
Analogue Social Anxiety Disorder Status
Time Frame: Week 1
|
Psychiatric Diagnostic Screening Questionnaire Social Anxiety Disorder subscale score of 4 or greater (Zimmerman & Mattia, 2001)
|
Week 1
|
|
Analogue Social Anxiety Disorder Status
Time Frame: Week 4
|
Psychiatric Diagnostic Screening Questionnaire Social Anxiety Disorder subscale score of 4 or greater (Zimmerman & Mattia, 2001)
|
Week 4
|
|
Analogue Social Anxiety Disorder Status
Time Frame: Week 8
|
Psychiatric Diagnostic Screening Questionnaire Social Anxiety Disorder subscale score of 4 or greater (Zimmerman & Mattia, 2001)
|
Week 8
|
|
Analogue Social Anxiety Disorder Status
Time Frame: Week 12
|
Psychiatric Diagnostic Screening Questionnaire Social Anxiety Disorder subscale score of 4 or greater (Zimmerman & Mattia, 2001)
|
Week 12
|
|
Sleep Quality
Time Frame: Baseline
|
Pittsburgh Sleep Quality Index (Buysse et al., 1989)
|
Baseline
|
|
Sleep Quality
Time Frame: Week 1
|
Pittsburgh Sleep Quality Index (Buysse et al., 1989)
|
Week 1
|
|
Sleep Quality
Time Frame: Week 4
|
Pittsburgh Sleep Quality Index (Buysse et al., 1989)
|
Week 4
|
|
Sleep Quality
Time Frame: Week 8
|
Pittsburgh Sleep Quality Index (Buysse et al., 1989)
|
Week 8
|
|
Sleep Quality
Time Frame: Week 12
|
Pittsburgh Sleep Quality Index (Buysse et al., 1989)
|
Week 12
|
|
Irritability Symptoms
Time Frame: Baseline
|
21-item Irritability Questionnaire (Craig et al., 2008)
|
Baseline
|
|
Irritability Symptoms
Time Frame: Week 1
|
21-item Irritability Questionnaire (Craig et al., 2008)
|
Week 1
|
|
Irritability Symptoms
Time Frame: Week 4
|
21-item Irritability Questionnaire (Craig et al., 2008)
|
Week 4
|
|
Irritability Symptoms
Time Frame: Week 8
|
21-item Irritability Questionnaire (Craig et al., 2008)
|
Week 8
|
|
Irritability Symptoms
Time Frame: Week 12
|
21-item Irritability Questionnaire (Craig et al., 2008)
|
Week 12
|
|
Rumination
Time Frame: Baseline
|
Rumination-Reflection Questionnaire (Trapnell and Campbell, 1999)
|
Baseline
|
|
Rumination
Time Frame: Week 1
|
Rumination-Reflection Questionnaire (Trapnell and Campbell, 1999)
|
Week 1
|
|
Rumination
Time Frame: Week 4
|
Rumination-Reflection Questionnaire (Trapnell and Campbell, 1999)
|
Week 4
|
|
Rumination
Time Frame: Week 8
|
Rumination-Reflection Questionnaire (Trapnell and Campbell, 1999)
|
Week 8
|
|
Rumination
Time Frame: Week 12
|
Rumination-Reflection Questionnaire (Trapnell and Campbell, 1999)
|
Week 12
|
|
Cognitive Functioning
Time Frame: Baseline
|
Stroop Colour and Word Test (Williams et al., 1996)
|
Baseline
|
|
Cognitive Functioning
Time Frame: Pre-acute resistance exercise bout week 1
|
Stroop Colour and Word Test (Williams et al., 1996)
|
Pre-acute resistance exercise bout week 1
|
|
Cognitive Functioning
Time Frame: Post-acute resistance exercise bout week 1
|
Stroop Colour and Word Test (Williams et al., 1996)
|
Post-acute resistance exercise bout week 1
|
|
Cognitive Functioning
Time Frame: Pre-acute resistance exercise bout week 8
|
Stroop Colour and Word Test (Williams et al., 1996)
|
Pre-acute resistance exercise bout week 8
|
|
Cognitive Functioning
Time Frame: Post-acute resistance exercise bout week 8
|
Stroop Colour and Word Test (Williams et al., 1996)
|
Post-acute resistance exercise bout week 8
|
|
Cognitive Functioning
Time Frame: Week 8
|
Stroop Colour and Word Test (Williams et al., 1996)
|
Week 8
|
|
Cognitive Functioning
Time Frame: Baseline
|
Trail Making Test (Tombaugh, 2004)
|
Baseline
|
|
Cognitive Functioning
Time Frame: Pre-acute resistance exercise bout week 1
|
Trail Making Test (Tombaugh, 2004)
|
Pre-acute resistance exercise bout week 1
|
|
Cognitive Functioning
Time Frame: Post-acute resistance exercise bout week 1
|
Trail Making Test (Tombaugh, 2004)
|
Post-acute resistance exercise bout week 1
|
|
Cognitive Functioning
Time Frame: Pre-acute resistance exercise bout week 8
|
Trail Making Test (Tombaugh, 2004)
|
Pre-acute resistance exercise bout week 8
|
|
Cognitive Functioning
Time Frame: Post-acute resistance exercise bout week 8
|
Trail Making Test (Tombaugh, 2004)
|
Post-acute resistance exercise bout week 8
|
|
Cognitive Functioning
Time Frame: Week 8
|
Trail Making Test (Tombaugh, 2004)
|
Week 8
|
|
Resistance Exercise Expectations
Time Frame: Baseline
|
15-item Expected Psychological Outcomes of Resistance Exercise Training (EPO-RET) questionnaire, derived from the Expected Psychological Outcomes of Exercise Questionnaire (Lindheimer et al., 2020).
Participants were asked "For each of the below outcomes, think about how you would expect to feel after completing a resistance exercise program (2 sessions per week for 8-12 weeks) relative to how you typically feel".
|
Baseline
|
|
Resistance Exercise Expectations
Time Frame: Week 1
|
15-item Expected Psychological Outcomes of Resistance Exercise Training (EPO-RET) questionnaire, derived from the Expected Psychological Outcomes of Exercise Questionnaire (Lindheimer et al., 2020).
Participants were asked "For each of the below outcomes, think about how you would expect to feel after completing a resistance exercise program (2 sessions per week for 8-12 weeks) relative to how you typically feel".
|
Week 1
|
|
Resistance Exercise Expectations
Time Frame: Week 4
|
15-item Expected Psychological Outcomes of Resistance Exercise Training (EPO-RET) questionnaire, derived from the Expected Psychological Outcomes of Exercise Questionnaire (Lindheimer et al., 2020).
Participants were asked "For each of the below outcomes, think about how you would expect to feel after completing a resistance exercise program (2 sessions per week for 8-12 weeks) relative to how you typically feel".
|
Week 4
|
|
Resistance Exercise Expectations
Time Frame: Week 8
|
15-item Expected Psychological Outcomes of Resistance Exercise Training (EPO-RET) questionnaire, derived from the Expected Psychological Outcomes of Exercise Questionnaire (Lindheimer et al., 2020).
Participants were asked "For each of the below outcomes, think about how you would expect to feel after completing a resistance exercise program (2 sessions per week for 8-12 weeks) relative to how you typically feel".
|
Week 8
|
|
Resistance Exercise Expectations
Time Frame: Week 12
|
15-item Expected Psychological Outcomes of Resistance Exercise Training (EPO-RET) questionnaire, derived from the Expected Psychological Outcomes of Exercise Questionnaire (Lindheimer et al., 2020).
Participants were asked "For each of the below outcomes, think about how you would expect to feel after completing a resistance exercise program (2 sessions per week for 8-12 weeks) relative to how you typically feel".
|
Week 12
|
|
Resistance Exercise Expectations
Time Frame: Pre-acute resistance exercise bout week 1
|
15-item Expected Psychological Outcomes of Acute Resistance Exercise (EPO-ARE) derived from the Expected Psychological Outcomes of Exercise Questionnaire (Lindheimer et al., 2020).
Participants are asked to "think about how you would expect to feel after one resistance exercise workout relative to how you typically feel".
|
Pre-acute resistance exercise bout week 1
|
|
Resistance Exercise Expectations
Time Frame: Post-acute resistance exercise bout week 1
|
15-item Expected Psychological Outcomes of Acute Resistance Exercise (EPO-ARE) derived from the Expected Psychological Outcomes of Exercise Questionnaire (Lindheimer et al., 2020).
Participants are asked to "think about how you would expect to feel after one resistance exercise workout relative to how you typically feel".
|
Post-acute resistance exercise bout week 1
|
|
Resistance Exercise Expectations
Time Frame: Pre-acute resistance exercise bout week 8
|
15-item Expected Psychological Outcomes of Acute Resistance Exercise (EPO-ARE) derived from the Expected Psychological Outcomes of Exercise Questionnaire (Lindheimer et al., 2020).
Participants are asked to "think about how you would expect to feel after one resistance exercise workout relative to how you typically feel".
|
Pre-acute resistance exercise bout week 8
|
|
Resistance Exercise Expectations
Time Frame: Post-acute resistance exercise bout week 8
|
15-item Expected Psychological Outcomes of Acute Resistance Exercise (EPO-ARE) derived from the Expected Psychological Outcomes of Exercise Questionnaire (Lindheimer et al., 2020).
Participants are asked to "think about how you would expect to feel after one resistance exercise workout relative to how you typically feel".
|
Post-acute resistance exercise bout week 8
|
|
Physical Activity
Time Frame: Baseline
|
7-day Physical Activity Recall (Blair et al., 1985)
|
Baseline
|
|
Physical Activity
Time Frame: Pre-week 1
|
7-day Physical Activity Recall (Blair et al., 1985)
|
Pre-week 1
|
|
Physical Activity
Time Frame: Week 1
|
7-day Physical Activity Recall (Blair et al., 1985)
|
Week 1
|
|
Physical Activity
Time Frame: Week 2
|
7-day Physical Activity Recall (Blair et al., 1985)
|
Week 2
|
|
Physical Activity
Time Frame: Week 3
|
7-day Physical Activity Recall (Blair et al., 1985)
|
Week 3
|
|
Physical Activity
Time Frame: Week 4
|
7-day Physical Activity Recall (Blair et al., 1985)
|
Week 4
|
|
Physical Activity
Time Frame: Week 5
|
7-day Physical Activity Recall (Blair et al., 1985)
|
Week 5
|
|
Physical Activity
Time Frame: Week 6
|
7-day Physical Activity Recall (Blair et al., 1985)
|
Week 6
|
|
Physical Activity
Time Frame: Week 7
|
7-day Physical Activity Recall (Blair et al., 1985)
|
Week 7
|
|
Physical Activity
Time Frame: Week 8
|
7-day Physical Activity Recall (Blair et al., 1985)
|
Week 8
|
|
Physical Activity
Time Frame: Week 12
|
7-day Physical Activity Recall (Blair et al., 1985)
|
Week 12
|
|
Muscle-Strengthening Exercise Activity
Time Frame: Baseline
|
Muscle-Strengthening Exercise Questionnaire - Short Version (Shakespear-Druery et al., 2022)
|
Baseline
|
|
Muscle-Strengthening Exercise Activity
Time Frame: Week 1
|
Muscle-Strengthening Exercise Questionnaire - Short Version (Shakespear-Druery et al., 2022)
|
Week 1
|
|
Muscle-Strengthening Exercise Activity
Time Frame: Week 4
|
Muscle-Strengthening Exercise Questionnaire - Short Version (Shakespear-Druery et al., 2022)
|
Week 4
|
|
Muscle-Strengthening Exercise Activity
Time Frame: Week 8
|
Muscle-Strengthening Exercise Questionnaire - Short Version (Shakespear-Druery et al., 2022)
|
Week 8
|
|
Muscle-Strengthening Exercise Activity
Time Frame: Week 12
|
Muscle-Strengthening Exercise Questionnaire - Short Version (Shakespear-Druery et al., 2022)
|
Week 12
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Matthew P. Herring, PhD, University of Limerick
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 9, 2023
Primary Completion (Actual)
January 5, 2025
Study Completion (Actual)
January 5, 2025
Study Registration Dates
First Submitted
January 20, 2025
First Submitted That Met QC Criteria
January 27, 2025
First Posted (Actual)
March 25, 2025
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
January 27, 2025
Last Verified
January 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2017_03_18_EHS_new
- GOIPG/2023/4158 (Other Grant/Funding Number: Taighde Éireann - Research Ireland)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
De-identified individual participant data for all primary and secondary outcomes measures will be made available.
IPD Sharing Time Frame
Primary outcome data will be made available for five years at six months following publication of primary outcome summary data.
Secondary outcome data will be made available for five years at six months following publications of secondary outcome summary data.
IPD Sharing Access Criteria
Proposals should be directed to matthew.herring@ul.ie.
To gain access, data requestors will need to sign a data access agreement.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Analogue Generalized Anxiety Disorder
-
University of LimerickIrish Research CouncilCompleted
-
University of Southern CaliforniaNational Institute of Mental Health (NIMH)RecruitingGeneralized Anxiety Disorder (GAD)United States
-
Florida State UniversityRecruitingAnxiety | Generalized Anxiety Disorder (GAD) | WorryingUnited States
-
Wayne State UniversityNational Institute of Mental Health (NIMH)RecruitingAnxiety Disorders | Generalized Anxiety Disorder (GAD)United States
-
AbbVieRecruitingGeneralized Anxiety Disorder (GAD)United States, Puerto Rico
-
Texas Tech UniversityRecruitingGrief | Anxiety Disorder Generalized | Depression in AdultsUnited States
-
University of California, IrvineNational Center for Complementary and Integrative Health (NCCIH)Not yet recruitingMajor Depressive Disorder | Generalized Anxiety Disorder (GAD)
-
PsyScaleNot yet recruitingMajor Depressive Disorder (MDD) | Generalized Anxiety Disorder (GAD)
-
National Health Research Institutes, TaiwanNot yet recruitingMajor Depressive Disorder (MDD) | Generalized Anxiety Disorder (GAD)
-
Psicofarma, S.A. De C.V.Recruiting
Clinical Trials on Moderate-to-High Intensity Resistance Exercise Training
-
Riphah International UniversityCompleted
-
Riphah International UniversityCompletedSports Physical TherapyPakistan
-
University of Colorado, DenverGilead Sciences; National Institute on Aging (NIA)CompletedInflammation | Obesity | HIV | Aging, BiologicalUnited States
-
Virginia Commonwealth UniversityRecruitingPeripheral Vascular DiseasesUnited States
-
University of Central ArkansasCompletedType 2 DiabetesUnited States
-
Norwegian University of Science and TechnologyCompletedMyocardial Infarction | Heart FailureNorway
-
Riphah International UniversityCompletedPolycystic Ovary SyndromePakistan
-
Yasemin ASLAN KELEŞIstanbul University - Cerrahpasa (IUC)CompletedEnd Stage Renal Disease | Exercise, CompulsiveTurkey
-
Peking University Third HospitalRecruitingObesity | Metabolic SyndromeChina
-
University of Castilla-La ManchaMinisterio de Economía y Competitividad, Spain; Biomedical Research Networking...CompletedFrail Elderly Syndrome | Sarcopenia | AgingSpain